TTKHLTCARE Stock Overview
Engages in the animal welfare and human pharma product, consumer product, medical device, protective device, food, and other businesses in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
TTK Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,336.65 |
| 52 Week High | ₹1,893.95 |
| 52 Week Low | ₹1,310.15 |
| Beta | 0.73 |
| 1 Month Change | -10.39% |
| 3 Month Change | -19.06% |
| 1 Year Change | -4.38% |
| 3 Year Change | 89.29% |
| 5 Year Change | 139.11% |
| Change since IPO | 363.63% |
Recent News & Updates
Recent updates
TTK Healthcare (NSE:TTKHLTCARE) Has Affirmed Its Dividend Of ₹10.00
Jul 16
TTK Healthcare (NSE:TTKHLTCARE) Is Paying Out A Dividend Of ₹10.00
Jul 02Estimating The Fair Value Of TTK Healthcare Limited (NSE:TTKHLTCARE)
Mar 04Is Now The Time To Put TTK Healthcare (NSE:TTKHLTCARE) On Your Watchlist?
Jun 04Is TTK Healthcare Limited (NSE:TTKHLTCARE) A Good Fit For Your Dividend Portfolio?
Mar 17Here's Why TTK Healthcare (NSE:TTKHLTCARE) Can Manage Its Debt Responsibly
Feb 22TTK Healthcare Limited (NSE:TTKHLTCARE) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Feb 02A Look At TTK Healthcare's (NSE:TTKHLTCARE) Share Price Returns
Jan 19
Our Take On TTK Healthcare's (NSE:TTKHLTCARE) CEO Salary
Jan 01Is TTK Healthcare Limited (NSE:TTKHLTCARE) A Good Fit For Your Dividend Portfolio?
Dec 16Is There More To The Story Than TTK Healthcare's (NSE:TTKHLTCARE) Earnings Growth?
Dec 01Is TTK Healthcare (NSE:TTKHLTCARE) A Risky Investment?
Nov 16Is The Market Rewarding TTK Healthcare Limited (NSE:TTKHLTCARE) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
Oct 21How Is TTK Healthcare's (NSE:TTKHLTCARE) CEO Paid Relative To Peers?
Sep 21Do These 3 Checks Before Buying TTK Healthcare Limited (NSE:TTKHLTCARE) For Its Upcoming Dividend
Aug 29TTK Healthcare's (NSE:TTKHLTCARE) Shareholders Are Down 36% On Their Shares
Aug 21Are Dividend Investors Getting More Than They Bargained For With TTK Healthcare Limited's (NSE:TTKHLTCARE) Dividend?
Jul 24Shareholder Returns
| TTKHLTCARE | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -5.7% | -2.4% | -3.3% |
| 1Y | -4.4% | 32.1% | 13.4% |
Return vs Industry: TTKHLTCARE underperformed the Indian Pharmaceuticals industry which returned 32.1% over the past year.
Return vs Market: TTKHLTCARE underperformed the Indian Market which returned 13.4% over the past year.
Price Volatility
| TTKHLTCARE volatility | |
|---|---|
| TTKHLTCARE Average Weekly Movement | 3.6% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: TTKHLTCARE has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: TTKHLTCARE's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1928 | 1,316 | S. Kalyanaraman | www.ttkhealthcare.com |
TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, Human Pharma, and Others segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, anti-parasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents.
TTK Healthcare Limited Fundamentals Summary
| TTKHLTCARE fundamental statistics | |
|---|---|
| Market cap | ₹18.59b |
| Earnings (TTM) | ₹799.43m |
| Revenue (TTM) | ₹7.71b |
23.3x
P/E Ratio2.4x
P/S RatioIs TTKHLTCARE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TTKHLTCARE income statement (TTM) | |
|---|---|
| Revenue | ₹7.71b |
| Cost of Revenue | ₹3.71b |
| Gross Profit | ₹4.01b |
| Other Expenses | ₹3.21b |
| Earnings | ₹799.43m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 24, 2025
| Earnings per share (EPS) | 56.58 |
| Gross Margin | 51.94% |
| Net Profit Margin | 10.36% |
| Debt/Equity Ratio | 2.9% |
How did TTKHLTCARE perform over the long term?
See historical performance and comparisonDividends
0.8%
Current Dividend Yield22%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 19:20 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
TTK Healthcare Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anil Burra | FirstCall Research |